COVID-19 funding

COVID-19 research news

Visit the University's COVID-19 Research website for the latest information from COVID-19 research experts, details on current projects being undertaken by our researchers and other key resources. 

Learn more

Funding opportunity summary Internal deadline

NIH: National Institute of Allergy & Infectious Diseases, US
Notice of special interest - Emergency competitive revisions for research on SARS-CoV-2 and COVID-19

Supports the construction of further infrastructure for the research response to the coronavirus disease 2019. The maximum project duration is two years.

25 Jun 2021

NIH: National Institute of Allergy & Infectious Diseases, US
Notice of special interest - Emergency awards for limited clinical trials to evaluate therapeutic and vaccine candidates against SARS-CoV-2

Supports investigator-initiated high-risk clinical trials to evaluate SARS-CoV-2 candidate vaccines, non-vaccine biomedical prevention of SARS-CoV-2 infection and COVID-19, and therapeutic approaches to treat COVID-19. Applications accepted every month until September 2021.

7 Sep 2021

US Department of Health & Human Services, US
Treatment and protection from COVID-19 broad agency announcement

Supports COVID-19-related research initiatives with a focus on plasma and therapeutics. Applications accepted until August 2022.

25 Jul 2022

Department of Health & Social Care including NIHR, GB
COVID-19 rapid response rolling call

This supports COVID-19 urgent public health research to gather the necessary clinical and epidemiological evidence that will inform national policy and enable new diagnostic tests, treatments and vaccines to be developed and tested for COVID-19.

  • Size of grant varies
  • UofA researchers can only be listed as CIs or subcontractors
  • Applications accepted at any time
  • Further information

Draper Richards Kaplan Foundation, US
COVID-19 urgent response initiative

Supports innovative solutions that address time-critical social problems caused by the COVID-19 pandemic. Grants should generally cover up to 25 per cent of eligible project costs.

  • USD $50,000 - $100,000 (approx. AUD $76,000 - $152,000)
  • Applications accepted at any time
  • Further information

European Spallation Source, SE
Deuteration and macromolecular crystallisation platform access for COVID-19 research

Enables scientists and researchers working on COVID-19-related research projects to access laboratory services through the deuteration and macromolecular crystallisation platform at the European Spallation Source. 


      European Synchrotron Radiation Facility (ESRF), EU
      COVID-19 scientific research

      Supports urgent research projects on COVID-19 by enabling researchers to access ESRF facilities.


      Google, US
      COVID-19 research grants

      Support researchers working on urgent public health challenges associated with COVID-19. Credits may be used to access computing software.


      Merck, DE
      Pandemic preparedness and fighting emerging new viral infectious disease

      Supports projects that leverage modern technologies to create new breakthrough solutions to be more prepared for pandemic outbreaks or work towards existing solutions that could help to fight emerging viral infections.


      Mozilla Foundation, US
      COVID-19 solutions fund

      Supports open-source technology projects which are responsive to the COVID-19 pandemic. Project duration of up to three months.


        Open Road Alliance, US
        COVID-19 charitable grants

        Supports charitable organisations that are responding directly to COVID-19. 

        • Up to USD $100,000 (approx. AUD $157,000)
        • Applications accepted at any time
        • Further information

          US Department of Energy, US
          COVID-19 high performance computing consortium

          Enables researchers carrying out COVID-19-related projects to access computing resources made available by partner institutions. The maximum project duration is six months.